1-92030225-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173567.5(EPHX4):āc.146A>Gā(p.Gln49Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000623 in 1,605,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173567.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHX4 | NM_173567.5 | c.146A>G | p.Gln49Arg | missense_variant | 1/7 | ENST00000370383.5 | NP_775838.3 | |
LOC124904218 | XR_007066222.1 | n.163T>C | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHX4 | ENST00000370383.5 | c.146A>G | p.Gln49Arg | missense_variant | 1/7 | 1 | NM_173567.5 | ENSP00000359410 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152058Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000745 AC: 17AN: 228286Hom.: 0 AF XY: 0.0000644 AC XY: 8AN XY: 124246
GnomAD4 exome AF: 0.0000330 AC: 48AN: 1452824Hom.: 0 Cov.: 31 AF XY: 0.0000263 AC XY: 19AN XY: 721970
GnomAD4 genome AF: 0.000342 AC: 52AN: 152176Hom.: 0 Cov.: 31 AF XY: 0.000390 AC XY: 29AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.146A>G (p.Q49R) alteration is located in exon 1 (coding exon 1) of the EPHX4 gene. This alteration results from a A to G substitution at nucleotide position 146, causing the glutamine (Q) at amino acid position 49 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at